Concord Drugs Ltd Share Price
As on 17 April 2025 at 20:15 IST
The Current prices are delayed, log in for live prices
LOGINOver 1 Month
-7.96%
Over 6 Months
-16.25%
Over 1 Year
-14.45%
Over 3 Years
2.05%
Concord Drugs Ltd Summary
Close
₹31.33
Open
₹30.53
High
₹31.88
Low
₹30.53
Volume
14,600
Net Turnover (in Cr)
₹0.045
52Wk High
₹44.96
52Wk Low
₹26.10
52Wk High / Low
26.10
44.96
Concord Drugs Ltd Fundamentals
Key Financial Data
Market Cap (in Cr)
₹31.33
EPS (TTM)
-
Book Value (BV)
33.88
Div. Yield
-
P/E (TTM)
-447.57
Price/Book Value
0.92
Delivery %
75.86
%
Face Value
10
Key Ratios
PE Ratio
83.74
PB Ratio
1.04
EV to Sales
1.15
PEG Ratio
-1.49
ROA
0.82
ROE
1.28
Debt-Equity
0.47
Net Profit Margin
0.97
Operating Profit Margin
8.53
Concord Drugs Ltd Financials
Profit and Loss
| Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|
| Total Revenue | 44.93 | 52.09 | 59.06 |
| Total Expenses | 44.30 | 50.84 | 56.81 |
| Profit Before Tax | 0.63 | 1.25 | 2.25 |
| Profit After Tax | 0.47 | 0.99 | 1.59 |
| Operating Profit After Depreciation | 2.50 | 2.96 | 3.93 |
Balance Sheet
| Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|
| Fixed Assets | 11.04 | 12.28 | 13.33 |
| Total Non Current Assets | 14.19 | 14.77 | 14.55 |
| Total Current Assets | 44.62 | 43.46 | 41.89 |
| Total Assets | 58.81 | 58.23 | 56.45 |
| Total Shareholder's Fund | 33.82 | 31.70 | 28.36 |
Cash Flow
| Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|
| Net Cash From Operating Activities | 0.79 | 1.66 | 0.77 |
| Net Cash Used In Investing Activities | -1.01 | -2.27 | -2.44 |
| Net Cash Used In Financing Activities | 0.28 | 0.62 | 1.68 |
Profit and Loss
| Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Total Revenue | 43.27 | 51.32 | 59.06 | 51.45 | 51.46 |
| Total Expenses | 42.71 | 50.20 | 56.81 | 50.92 | 51 |
| Profit Before Tax | 0.56 | 1.13 | 2.25 | 4.29 | 0.46 |
| Profit After Tax | 0.42 | 0.89 | 1.59 | 3.28 | 0.33 |
| Operating Profit After Depreciation | 2.15 | 2.75 | 3.93 | 1.95 | 2 |
Balance Sheet
| Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Fixed Assets | 10.99 | 12.22 | 13.33 | 13.19 | 9.74 |
| Total Non Current Assets | 14.92 | 15.23 | 14.55 | 13.86 | 12.45 |
| Total Current Assets | 41.38 | 41.40 | 41.89 | 36.03 | 45.56 |
| Total Assets | 56.30 | 56.63 | 56.45 | 49.88 | 58.02 |
| Total Shareholder's Fund | 33.82 | 31.70 | 28.36 | 26.77 | 23.48 |
Cash Flow
| Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | 1.96 | 2.24 | 0.77 | 1.62 | 2.48 |
| Net Cash Used In Investing Activities | -1.21 | -2.27 | -2.44 | -3.67 | -0.84 |
| Net Cash Used In Financing Activities | -0.69 | 0.05 | 1.68 | 2.07 | -1.79 |
| Particulars (in ₹ Cr.) | 2024-12 | 2024-09 | 2024-06 | 2024-03 | 2023-12 |
|---|---|---|---|---|---|
| Total Revenue | 10.80 | 12.37 | 11.69 | 15.64 | 12.78 |
| Total Expenses | 9.41 | 11.50 | 10.86 | 15.30 | 12.15 |
| Profit Before Tax | 0.52 | 0.06 | 0.04 | -0.55 | -0.26 |
| Profit After Tax | 0.23 | 0.04 | 0.03 | -0.34 | -0.24 |
| Operating Profit after Depreciation | 1.39 | 0.87 | 0.83 | 0.34 | 0.63 |
| Particulars (in ₹ Cr.) | 2024-12 | 2024-09 | 2024-06 | 2024-03 | 2023-12 |
|---|---|---|---|---|---|
| Total Revenue | 10.77 | 11.84 | 6.35 | 14.47 | 12.62 |
| Total Expenses | 9.46 | 11.05 | 5.62 | 14.28 | 12.07 |
| Profit Before Tax | 0.51 | 0.07 | 0.02 | -0.58 | -0.26 |
| Profit After Tax | 0.22 | 0.05 | 0.01 | -0.35 | -0.24 |
| Operating Profit after Depreciation | 1.31 | 0.80 | 0.73 | 0.19 | 0.55 |
Concord Drugs Ltd Technicals
Support and Resistance
S3
S2
S1
Pivot
R1
R2
R3
S1
30.61
S2
29.90
S3
29.26
Pivot
31.25
R1
31.96
R2
32.60
R3
33.31
Moving Average
20 SMA
31.88
50 SMA
32.90
100 SMA
34.84
200 SMA
35.99
Concord Drugs Ltd Corporate Actions
No available data
Concord Drugs Ltd Peer Comparison
| Company | Price | Market Cap (in Cr) |
|---|---|---|
| Sun Pharmaceutical Industries Ltd | ₹1,692.65 | ₹4,06,123.43 |
| Divis Laboratories Ltd | ₹5,757.50 | ₹1,52,843.53 |
| Cipla Ltd | ₹1,496.50 | ₹1,20,859.90 |
| Torrent Pharmaceuticals Ltd | ₹3,221.20 | ₹1,09,015.15 |
| Mankind Pharma Ltd | ₹2,522.45 | ₹1,04,070.87 |
Concord Drugs Ltd Top Mutal Funds Invested
No data available
Concord Drugs Ltd News
Concord Drugs postpones board meeting
To 17 March 2025
14 Mar 2025, 10:07 am
Concord Drugs to convene board meeting
On 13 March 2025
05 Mar 2025, 09:36 am
Concord Drugs to table results
On 11 January 2025
08 Jan 2025, 10:15 am
Concord Drugs announces board meeting date
On 13 November 2024
08 Nov 2024, 12:33 pm
Concord Drugs to conduct AGM
On 30 September 2024
19 Sep 2024, 05:57 pm
Concord Drugs Ltd Stock Analysis
- Annual revenue for Concord Drugs Ltd decreased by 15.69% to ₹43.27 crore in FY 2024 from ₹51.32 crore in FY 2023.
- Annual Net Profit for Concord Drugs Ltd decreased by 52.99% to ₹0.42 crore in FY 2024 from ₹0.89 crore in FY 2023.
- Promoter Shareholding in Concord Drugs Ltd remains unchanged by 0.00% in the most recent quarter, from 54.39% in December 2024 to 54.39% in March 2025.
- Concord Drugs Ltd delivered a 1-year return of -14.45% compared to the Nifty 50, which provided a return of 5.82% as of the last trading session.
- Concord Drugs Ltd share price moved down by 1.92% from its previous close of INR ₹31.33. The latest Concord Drugs Ltd share price is INR ₹30.73.
- Concord Drugs Ltd share price today has been at a low of 30.60 and a high of 31.99. Over the past 52 weeks, the Concord Drugs Ltd share price has seen a low of 26.10 and a high of 44.96.
FAQ’s
What is the share price of Concord Drugs Ltd today?
Concord Drugs Ltd share price as on 17 Apr 2025 is ₹
30.73
What is the Market Cap of Concord Drugs Ltd?
The market cap of Concord Drugs Ltd stock is ₹31.33 Cr.
What is the PE Ratio of Concord Drugs Ltd?
The Price to Earnings (P/E) Ratio of Concord Drugs Ltd is 83.74
What is the PB Ratio of Concord Drugs Ltd?
The Price to Book (P/B) Ratio of Concord Drugs Ltd is 1.04
What is the 52 week high of Concord Drugs Ltd Share Price?
The 52 week high of Concord Drugs Ltd share price stands at ₹44.96
What is the 52 week low of Concord Drugs Ltd Share Price?
The 52 week low of Concord Drugs Ltd share price stands at ₹26.10
How can I buy shares of Concord Drugs Ltd?
Simply open a demat account with Torus Digital and place an order to buy shares of Concord Drugs Ltd.
Open FREE
3-in-1 Account
for all your banking, trading and demat needs
Trade in stocks,
derivatives and F&O
